The sector is defensive, and biopharmaceuticals have, for the most part, limited tariff and transfer price exposure, he ...

With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.

During the fourth quarter, the Harbor Health Care ETF returned –10.89%, underperforming the Russell 3000 Growth Health Care ...

BIOG’s performance has been particularly challenging as the managers favour emerging (less mature) biotech companies, which have fared particularly poorly versus the S&P 500 during the longest and ...

The current macro environment appears grim, given the uncertainty around the global trade war, along with ongoing ...

"China's biotechnology sector thrives on a dual engine ... giants stems partly from the remarkable global market performance of its homegrown innovative drugs. Akeso Inc, a startup based ...

Many experts rank BMRN as one of the most profitable stocks in the biotech industry due to its solid financial performance and potential for future growth. The company is working on its ...

The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due to the better-than-expected fourth-quarter performance of large ...

From lab-grown actives to eco-friendly formulations, we reveal how biotech is reshaping the future of skin care, plus a round ...

seamlessly blending cutting-edge biotechnology with high-performance color. Founded by cosmetic chemist Alanna Tran, this clinically backed brand is redefining the industry by offering makeup ...

While researchers discovered IgE antibodies all the way back in 1966, and biologics pioneers considered them at the birth of the biotech industry ... the clinical performance of antibodies.” ...